BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 18644240)

  • 1. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series.
    Schwartz S; Joseph C; Iera D; Vu DD
    J Can Dent Assoc; 2008; 74(6):537-42. PubMed ID: 18644240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dental implications of osteogenesis imperfecta: treatment with IV bisphosphonate: report of a case.
    Milano M; Wright T; Loechner KJ
    Pediatr Dent; 2011; 33(4):349-52. PubMed ID: 21903004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates.
    Malmgren B; Aström E; Söderhäll S
    J Oral Pathol Med; 2008 Apr; 37(4):196-200. PubMed ID: 18321345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates and orthodontics.
    Goss AN
    Aust Orthod J; 2008 May; 24(1):56-7. PubMed ID: 18649566
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-induced osteonecrosis of the jaw.
    Krueger CD; West PM; Sargent M; Lodolce AE; Pickard AS
    Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L; Masood F
    J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bisphosphonate-associated osteonecrosis of the jaws. 2. Six case reports].
    Kicken M; Van Cann EM; Koole R
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):428-31. PubMed ID: 17972611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
    Carmagnola D; Celestino S; Abati S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e10-5. PubMed ID: 18801674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
    Brown JJ; Ramalingam L; Zacharin MR
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteogenesis imperfecta.
    Huber MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):314-20. PubMed ID: 17223585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.
    Bagan JV; Jimenez Y; Murillo J; Hernandez S; Poveda R; Sanchis JM; Diaz JM; Scully C
    Oral Oncol; 2006 Mar; 42(3):327-9. PubMed ID: 16275156
    [No Abstract]   [Full Text] [Related]  

  • 13. Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series.
    Lodi G; Sardella A; Salis A; Demarosi F; Tarozzi M; Carrassi A
    J Oral Maxillofac Surg; 2010 Jan; 68(1):107-10. PubMed ID: 20006163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates and osteonecrosis of the jaws.
    Mariotti A
    J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta.
    Kamoun-Goldrat A; Ginisty D; Le Merrer M
    Eur J Oral Sci; 2008 Jun; 116(3):195-8. PubMed ID: 18471236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE; Umland EM
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm.
    Malden N; Beltes C; Lopes V
    Br Dent J; 2009 Jan; 206(2):93-8. PubMed ID: 19165270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteonecrosis of the jaw and bisphophonates in oncology].
    Facon T; Bensadoun RJ; Blanc JL; Confavreux C; Gourmet R; Maes JM; Penel G; Vieillard MH; Woeller A
    Bull Cancer; 2008 Apr; 95(4):413-8. PubMed ID: 18495570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.